Bellevue Asset Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

Bellevue Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$21.52 - $36.02 $731 - $1,224	-34 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$39.41 - $47.25 $157 - $189	-4 Reduced 10.53%	34 $2,000
Q1 2021 May 12, 2021	BUY	$43.34 - $65.91 $606 - $922	14 Added 58.33%	38 $2,000
Q4 2020 Feb 11, 2021	BUY	$23.3 - $59.57 $559 - $1,429	24 New	24 $1,000

243

106M

268K

119K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $792M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.